To evaluate the impact of the Medical Guard Diabetes® telematic system - as a telematic communication system which allows transmitting the results of capillary glucose readings, insulin doses, carbohydrate intake in foods and other events from home or other places to the medical team through a web server- on the effectiveness of financial and clinical management of human resources and materials intended for a program for optimizing metabolic control in patients with type 1 diabetes mellitus, considering the degree of metabolic control and patients’ quality of life.
The Telemed-diabetes study is crucial for comparing the cost and effectiveness parameters of two control optimization programs by means of physical visits or substituting some physical visits by means of a telematic communication system.
Telemed-diabetes is an open, comparative, prospective, randomized, multi-centre study (five participating centres) which will allow knowing the effectiveness and usefulness of the program with telematic communication by means of assessment and comparison between the two groups of participating patients by means of the results of:
April 2011 - April 2012: Implementation of the Telemed-diabetes study.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) - Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (Ministerio de Economía y Competitividad) (ISCIII, MINECO).